Ruti Aga: Six-Year Ban Over Fake Prescription Effectively Ends Marathon Career

Ethiopian women's marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU). The case is not merely about a doping violation, but about an entirely fabricated medical document prepared by a family member. The verdict exposes a bitter reality of sports governance: many athletes in African road running compete without professional medical support and turn to informal channels in times of crisis. According to reports, Aga won a half marathon in China in March. A sample taken after that race tested positive for methylprednisolone, a glucocorticoid classified as class S9 on the World Anti-Doping Agency (WADA) Prohibited List. It is not an anabolic steroid. S9 substances are prohibited only in-competition, and only when administered by injection, oral or rectal routes. In Aga's case, the decisive factor was not the medication itself but its presence in her body during competition. Several media reports described it as a steroid, which is technically incorrect and distorts the nature of the case. Aga told investigators that she was given the medication to treat a knee injury. She cited a clinic that does not actually exist. The prescription was written by a family member who was not a registered physician. That person claimed to have used an old prescription pad from the clinic's former workplace, but the clinic explicitly stated that no such pad belonged to them. The AIU independently verified all three points and found the entire medical record fabricated. The arithmetic of the sanction is clear: two years for the presence of the substance and four years for tampering with documents and giving misleading statements during the investigation, totaling six years. The ban is effective from 10 September, the date of her provisional suspension. The ban will run until she is approximately 38 years old. Competition in Ethiopian women's marathon is so fierce that a 38-year-old returning athlete with a doping record would stand virtually no chance of national team selection. In practical terms, this is a lifetime ban. Aga's biggest achievement is the 2026 Tokyo Marathon title, part of the World Marathon Majors. She also finished second three times at World Marathon Majors. Her personal best is believed to be around 2:18:34, recorded at the 2026 Berlin Marathon where she finished second. These results date from when she was a world-class elite marathoner. Since the violation relates to a later competition and no evidence of earlier use was found, results up to 2026 have not been annulled in the normal course. However, the result and prize money from the March race where the sample was collected will certainly be voided, although the AIU statement does not explicitly say so. The most important lesson from this case is that the medication that caused Aga's ban should not have been taken during competition. With a professional medical team, either a Therapeutic Use Exemption (TUE) would have been applied for or the athlete would have waited for the drug to clear her system before competing. Neither path was taken. Instead, fake documents were produced. That proved to be the biggest mistake, as it destroyed the defense that might have worked. Aga's case is not isolated. Several cases have emerged in East African road running where the first violation involved a substance and the second involved false information or forged documents during investigation. This shows that the AIU's enforcement is no longer limited to sample testing but has expanded to document verification. China's label race circuit, where many African athletes run for large appearance fees, has become a high-surveillance zone. From a sports governance perspective, the sanction is strict but within the rules. The two-year penalty suggests the panel treated the substance use as a mistake, but regarded the tampering as fully deliberate. Ironically, the forged documents were themselves evidence of intent to conceal, yet did not increase the substance penalty. For Aga, the decision effectively announces the end of her career. A six-year ban at age 32 means that by the time she is eligible to return, her competitive relevance will be over. It will have no effect on the Ethiopian women's marathon landscape, as several runners below 2:16 already exist there. The real concern is the integrity system of the sport, not competitive balance. The way fake medical networks operate connects multiple athletes at once, and more similar cases may emerge. From an administrative standpoint, it is also notable that no criminal action against the family member is mentioned. The AIU does not have jurisdiction to prosecute document forgery, but the case could have been referred to national authorities. It is unclear whether this happened. Nor is it clear whether the role of her management team or agent was investigated. The AIU statement was issued on Thursday. It said only that Aga has been banned for six years and that she was provisionally suspended from 10 September. The statement did not give the year of the March race or its name, nor did it specify which results were annulled. It also did not say until what date the ban will run, though the arithmetic makes clear that the six-year period will run from 10 September for the next six years. Aga has the option to appeal to the Court of Arbitration for Sport (CAS), but it is unlikely that an appeal in a forged document case would succeed. Documentary evidence is strong and difficult to overturn. The whole episode raises a bigger question: is a six-year ban appropriate for a substance with no proven endurance benefit? The question matters because debate continues over the severity of enforcement against African road runners. The case will become an example for both sides. One side will see it as proof of AIU rigor, the other as a sample of inconsistent action. In the end, the saddest aspect of Aga's case is how short the path between injury and doping was. An elite marathon runner should have received proper medical assistance to treat a knee injury. If correct treatment had been available in time, things might have been different. But when medical support comes from informal networks, the risk increases. Having a fake prescription prepared becomes a way to manage the problem. The issue is systemic, not individual. And until the standard of professional medical support in the road running system improves, such cases will keep coming.